Globus Medical, Inc. GMED
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Matt O'Brien | Piper Sandler | 90.54 $ | 115 $ | 24.46 % | 08/01/2026 |
| Shagun Singh | RBC Capital | 85.79 $ | 100 $ | 14.21 % | 17/12/2025 |
| Caitlin Cronin | Canaccord Genuity | 85.79 $ | 105 $ | 19.21 % | 17/12/2025 |
| Thomas Stephan | Stifel Nicolaus | 63.455 $ | 64 $ | 0.55 % | 28/10/2025 |
| Kallum Titchmarsh | Morgan Stanley | 85.52 $ | 100 $ | 14.48 % | 02/12/2024 |
| Ryan Zimmerman | BTIG | 71.73 $ | 77 $ | 5.27 % | 28/08/2024 |
| Vik Chopra | Wells Fargo | 70.53 $ | 78 $ | 7.47 % | 07/08/2024 |
| Drew Ranieri | Morgan Stanley | 71.07 $ | 71 $ | -0.07 % | 15/07/2024 |
| Ryan Zimmerman | BTIG | 65.49 $ | 72 $ | 6.51 % | 29/05/2024 |
| Matt O'Brien | Piper Sandler | 64.4 $ | 80 $ | 15.60 % | 20/05/2024 |
| Ryan Zimmerman | BTIG | 51.65 $ | 60 $ | 8.35 % | 18/03/2024 |
| Mathew Blackman | Stifel Nicolaus | 53.04 $ | 61 $ | 7.96 % | 19/09/2023 |
| Craig Bijou | Bank of America Securities | 68.96 $ | 80 $ | 11.04 % | 13/12/2021 |
| Kyle Rose | Canaccord Genuity | 79.9 $ | 90 $ | 10.10 % | 05/08/2021 |
| Matthew Henriksson | Citigroup | 79.9 $ | 93 $ | 13.10 % | 05/08/2021 |
| Richard Newitter | Leerink Partners | 79.9 $ | 96 $ | 16.10 % | 05/08/2021 |
| Steven Lichtman | Oppenheimer | 73.37 $ | 79 $ | 5.63 % | 05/05/2021 |